Michael Cross, BioZorb, breast cancer, hypofractionated radiation therapy

Breast cancer research conducted by two Fayetteville, Arkansas, medical groups highlights their success in pioneering use of an absorbable, three-dimensional marker used during treatment for breast cancer. Their cost analysis, to be presented at an international breast cancer conference this week, showed that by helping to shorten the course of radiation treatments, the surgical marker contributed to a 25 percent cost savings per patient.

They were once the kings of computed tomography (CT) — 16-slice scanners that hinted at coronary CT angiography; 64 slicers that delivered it. Today they are entry level and mid-tier products: streamlined in function; optimized for dose; automated for efficiency; and reduced — dramatically — in price.

Beyond them at the high-end are premium scanners producing — even exceeding — 256 slices per rotation. Some can characterize tissue based on the atomic numbers of its elements, an extraordinary capability that puts CT on the cusp of molecular imaging.

Fetuses with enlarged ventricles — the fluid-filled cavities inside the brain — determined by magnetic resonance imaging (MRI) scans may be less likely to benefit from surgery in the womb to treat spina bifida, according to a National Institutes of Health-supported study.

Samsung has been awarded a group purchasing agreement for general radiography, computed tomography (CT) and ultrasound with Premier Inc., a leading healthcare improvement company, effective Oct. 1, 2015. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for digital radiography, CT, and ultrasound products.

IBA (Ion Beam Applications SA) announced that it has signed a contract with the company INVAP for the installation of a proton therapy center at the Instituto de Oncologia Angel Roffo hospital in Buenos Aires, Argentina.

Visit www.itnonline.com/events for a comprehensive list of upcoming radiology events.

Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal cancer.

Shimadzu Medical Systems USA announced the first Sonialvision G4 universal radiographic fluoroscopy (R/F) system installed in Canada.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now